Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, have been widely used to lower cholesterol and prevent cardiovascular diseases. Recent preclinical and clinical studies have shown that statins exert beneficial effects in the management of breast cancer, while the underlying me...
Main Authors: | Litian Yin, Zhongmei He, Bing Yi, Linyuan Xue, Jianxin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.574068/full |
Similar Items
-
Molecular mechanisms of toxicity of simvastatin, widely used cholesterol-lowering drug. A review
by: Kaminsky Yury, et al.
Published: (2010-06-01) -
Simvastatin Attenuates TGF-β1-Induced Epithelial-Mesenchymal Transition in Human Alveolar Epithelial Cells
by: Tuo Yang, et al.
Published: (2013-06-01) -
The potential use of simvastatin for cancer treatment: A review
by: Jaqueline Aparecida Duarte, et al.
Published: (2021-09-01) -
Simvastatin-induced nocturnal leg pain disappears with pravastatin substitution
by: Stojaković Nataša, et al.
Published: (2013-01-01) -
Simvastatin is effective in killing the radioresistant breast carcinoma cells
by: Aschenbrenner Bertram, et al.
Published: (2021-05-01)